STAT July 15, 2024
Ed Silverman

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so predictable routine of online meetings, phone calls, and deadlines has returned. But what can you do? The world, such as it is, continues to spin. So to nudge it in a better direction, we are brewing cups of stimulation. Our choice today is hazelnut mocha. Please feel free to join us. Meanwhile, here are a few tidbits for you to chew on as you start the day, which we hope is meaningful and productive. Best of luck and, as always, do keep in touch. …

Democratic U.S. Senate aides will meet with Novo Nordisk executives on Tuesday to discuss...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech
New 'how-to guide' for future rapid vaccine development
Infographic: R&D Spending Growth of Top Pharma Companies
Medicare prescription drug pricing variance: 5 things to know
Payer group 'deeply concerned' by Medicare weight loss drug coverage proposal
Adoption Of Model-Informed Drug Development Can Improve Pharma ROI

Share This Article